1. Home
  2. VOR vs FRNM Comparison

VOR vs FRNM Comparison

Compare VOR & FRNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

N/A

Current Price

$19.18

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

FRNM

Freenome Inc. Common stock

N/A

Current Price

$9.35

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VOR
FRNM
Founded
2015
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
VOR
FRNM
Price
$19.18
$9.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
5
Target Price
★ $39.00
$18.00
AVG Volume (30 Days)
636.5K
★ 754.8K
Earning Date
10-30-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$261.16
Revenue Next Year
N/A
$3.65
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.21
$9.60
52 Week High
$26.00
$17.50

Technical Indicators

Market Signals
Indicator
VOR
FRNM
Relative Strength Index (RSI) 48.50 30.93
Support Level $17.62 N/A
Resistance Level $20.11 $17.32
Average True Range (ATR) 1.29 0.86
MACD -0.09 -0.06
Stochastic Oscillator 44.48 0.47

Price Performance

Historical Comparison
VOR
FRNM

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: